Jennifer Kouznetsova

Author

National Center for Advancing Translational Sciences ORCID

Also Known As

Jennifer Kouznetsova

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

National Center for Advancing Translational Sciences National Institutes of Health Icahn School of Medicine at Mount Sinai University of Alabama at Birmingham Wellcome/MRC Cambridge Stem Cell Institute

About

Jennifer Kouznetsova is an author at National Center for Advancing Translational Sciences specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	459
2	Natural Sciences	4	4	204
3	Cell Biology	3	3	150
4	Immunology	2	2	294
5	Biochemistry	1	1	15

Jennifer Kouznetsova

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen Miao Xu, Emily M. Lee, Zhexing Wen, Nature Medicine	2016	660
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs Jennifer Kouznetsova, Wei Sun, Carles Martínez‐Romero, Emerging Microbes & Infections Drug TargetEbola InfectionMedicineBioanalysisImmunology	2014	240
Elabela-Apelin Receptor Signaling Pathway is Functional in Mammalian Systems Zhi Wang, Daozhan Yu, Mengqiao Wang, Scientific Reports	2015	195
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH) Ganesha Rai, Kyle R. Brimacombe, Bryan T. Mott, Journal of Medicinal Chemistry	2017	146
Synergistic drug combination effectively blocks Ebola virus infection Wei Sun, Shihua He, Carles Martínez‐Romero, Antiviral Research	2016	98
Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression Melanie A. Blevins, Jennifer Kouznetsova, Aaron Krueger, SLAS DISCOVERY Ctbp1-mediated Transcriptional RepressionMolecular BiologyCell DeathCancer BiologyTumor Biology	2014	77
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors Manu Anantpadma, Jennifer Kouznetsova, Hang Wang, Antimicrobial Agents and Chemotherapy Viral DiagnosticsViral PathogenesisImmunologyAntiviral DrugSmall Molecules	2016	54
A novel quantitative high-throughput screen identifies drugs that both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and facilitate neuroprotection in a model of oxygen and glucose deprivation Joshua D. Bernstock, Yang-ja Lee, Luca Peruzzotti‐Jametti, Journal of Cerebral Blood Flow & Metabolism Molecular BiologyRedox BiologyOxidative StressGlucose DeprivationLong Non-coding Rna	2015	38
Quantitative high‐throughput screening identifies cytoprotective molecules that enhance SUMO conjugation <i>via</i> the inhibition of SUMO‐specific protease (SENP)2 Joshua D. Bernstock, Daniel Ye, Jayden A. Smith, The FASEB Journal Identifies Cytoprotective MoleculesMolecular BiologySumo SystemOxidative StressCerebral Vascular Regulation	2017	35
Structure–activity relationship studies and biological characterization of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors Damien Duveau, Adam Yasgar, Yuhong Wang, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyAldo-keto ReductaseAldehyde DehydrogenaseBiochemistryMedicine	2013	15

Page 1